Angle PLC - Guildford, England-based liquid biopsy company - Hires Brett Swansiger as chief commercial officer and Karen Miller as chief scientific officer. Says Swansiger has over 20 years of experience within the molecular diagnostic and pharmaceutical industries. Most recently, he was COO at DxTerity Diagnostics, a biotechnology company based in the US. Says Miller brings a strong network of relationships within the pharmaceutical and companion diagnostic industries, having over 30 years of experience. She was most recently the CSO at Ixaka, a cell & gene therapy company. Start dates for both roles are undisclosed.

Chief Executive Officer Andrew Newland says: ‘I am delighted to be able to welcome these two highly accomplished individuals to the Angle management team. Brett and Karen bring valuable skills and networks that will play a key role in helping us deliver on our strategic and commercial objectives.’

Current stock price: 17.96 pence each, down 2.9% on Monday afternoon in London

12-month change: down 87%

Copyright 2023 Alliance News Ltd. All Rights Reserved.